Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation

NCT00348634 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00348634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00348634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2006
Completion date
April 30, 2007
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic constipation